At the news
? NEUTRALIMPACT 3/10 PRESS-RELEASE filed Mar 24, 2026 at 16:05 ET
TELA Bio reported financial results for Q4 and full year 2025. The press release announces earnings but contains no actual financial figures such as revenue, EPS, or guidance, limiting actionable insights.
- TELA Bio released financial results for Q4 and full year 2025.
- No quantitative financial data (revenue, EPS, margins, guidance) was disclosed in the provided text.
- Company described as commercial-stage with focus on soft-tissue reconstruction solutions.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access